SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-062249
Filing Date
2017-12-04
Accepted
2017-12-04 17:17:41
Documents
2
Period of Report
2017-12-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv480735_3.html 3  
1 OWNERSHIP DOCUMENT tv480735_3.xml 3 1629
2 EXHIBIT 24 tv480735_ex24.htm EX-24 6338
  Complete submission text file 0001144204-17-062249.txt   9577
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Issuer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AEVI GENOMIC MEDICINE, INC. 435 DEVON PARK DR., SUITE 715 WAYNE PA 19087
Business Address
Bayley Matthew D (Reporting) CIK: 0001723040 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35112 | Film No.: 171237890